Skip to main content

Diagnostic options Β· UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 751–765 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3312
P2RY12 Gene Platelet‑Type 8 Bleeding Disorder DNA Test

This test evaluates the P2RY12 gene for pathogenic variants associated with platelet-type 8 bleeding disorder.

Whole Blood, Extracted DNA, or FTA Card Blood Spot 14–21 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the P2RY12 gene"]
Parameters
[]
Preparation
["No fasting required", "Genetic counseling session advised beforehand"]
Indications
["Suspected inherited platelet disorder", "Family history of bleeding disorders", "Evaluation of platelet dysfunction"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92940-1 ICD-10: D69.1
Clinical summary
This test evaluates the P2RY12 gene for pathogenic variants associated with platelet-type 8 bleeding disorder.
TEST-5890
PAH Gene Phenylketonuria (PKU) Genetic Test

This test evaluates the PAH gene for pathogenic variants associated with phenylketonuria (PKU) and hyperphenylalaninemia.

Whole blood, extracted DNA, or FTA card 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PAH gene sequence", "Pathogenic variants in PAH gene"]
Parameters
[]
Preparation
["None specified"]
Indications
["Suspected PKU", "Family history of PKU", "Carrier screening", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: E70.0
Clinical summary
This test evaluates the PAH gene for pathogenic variants associated with phenylketonuria (PKU) and hyperphenylalaninemia.
TEST-2857
Pancreatic Polypeptide (PP) Test

This test measures the level of pancreatic polypeptide hormone in the blood to aid in the diagnosis and monitoring of pancreatic neuroendocrine tumors (pNETs) and MEN1 syndrome.

Plasma (EDTA) 2–3 Weeks (Batch Reporting Cycle) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pancreatic Polypeptide (PP) hormone levels", "Fasting blood concentration"]
Parameters
[{"name": "Pancreatic Polypeptide", "reference_range": "0.1 pmol/L (CLIA Method)"}]
Preparation
["Overnight fasting (8–12 hours) is required.", "A completed Test Send Out Consent Form (Form 35) is mandatory.", "Do not adjust or discontinue prescribed medications without consulting your physician."]
Indications
["Diagnosis of pancreatic neuroendocrine tumors (pNETs)", "Monitoring of known pNETs", "Screening for MEN1 syndrome", "Evaluation of patients with suspected neuroendocrine tumors"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 2794-8 ICD-10: C25.4, D37.7, Z15.09
Clinical summary
This test measures the level of pancreatic polypeptide hormone in the blood to aid in the diagnosis and monitoring of pancreatic neuroendocrine tumors (pNETs) and MEN1 syndrome.
TEST-4601
PARN Gene Pulmonary Fibrosis and Bone Marrow Failure, Telomere-Related Type 4 Genetic Test

This test identifies pathogenic variants in the PARN gene associated with telomere-related pulmonary fibrosis and bone marrow failure.

Peripheral Whole Blood, DNA extraction card, or extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the PARN gene", "Telomere biology related genetic risk"]
Parameters
[]
Preparation
["Pre-test genetic counselling session is mandatory", "Informed consent required"]
Indications
["Suspected hereditary telomere biology disorder", "Family history of pulmonary fibrosis or bone marrow failure", "Guidance for surveillance and family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21670-8 ICD-10: J84.10, D61.9
Clinical summary
This test identifies pathogenic variants in the PARN gene associated with telomere-related pulmonary fibrosis and bone marrow failure.
TEST-2864
Paroxetine Test (Therapeutic Drug Monitoring)

This test measures the concentration of paroxetine in the patient's serum to optimize therapeutic dosing and monitor for potential toxicity.

Serum 2–3 weeks 4,500.00 AED
View
View test specifications and preparation
What it measures
["Paroxetine concentration in serum"]
Parameters
[{"name": "Paroxetine", "reference_range": "20–60 ng/mL"}]
Preparation
["Collect blood sample just before next scheduled dose", "Ensure patient is at steady state (typically 5-7 days after dose change)", "Use red-top tube (no gel separator)", "Separate serum within 2 hours", "Refrigerate or freeze serum until shipment"]
Indications
["Initiation of paroxetine therapy", "Dose adjustments", "Monitoring for toxicity", "Assessing adherence", "Lack of therapeutic response"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 34891-4 ICD-10: ['Z51.81', 'F32.9', 'F41.9']
Clinical summary
This test measures the concentration of paroxetine in the patient's serum to optimize therapeutic dosing and monitor for potential toxicity.
TEST-3572
PAX6 Gene Coloboma of the Optic Nerve Genetic Test

This test evaluates the PAX6 gene for pathogenic variants associated with congenital optic nerve coloboma using next-generation sequencing.

Peripheral Whole Blood (EDTA), Saliva (FTA Card), or Extracted Genomic DNA 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PAX6 gene sequence variants (SNVs, indels)", "PAX6 gene copy-number variants (exon-level deletions/duplications)"]
Parameters
[]
Preparation
["No fasting required", "Pre-test genetic counseling with a detailed three-generation pedigree is mandatory"]
Indications
["Diagnosis of congenital optic nerve coloboma", "Genetic counseling for families with affected individuals", "Surveillance planning for associated systemic features"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94495-7 ICD-10: Q14.2, H47.31
Clinical summary
This test evaluates the PAX6 gene for pathogenic variants associated with congenital optic nerve coloboma using next-generation sequencing.
TEST-3631
PAX6 Gene Foveal Hypoplasia Type 1 Genetic Test

This genetic test identifies mutations within the PAX6 gene associated with congenital foveal hypoplasia and aniridia.

Whole Blood or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PAX6 gene mutations", "Copy Number Variations (CNVs) in PAX6 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication"]
Indications
["Confirmation of clinical diagnosis", "Guiding prognosis", "Family risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93296-9 ICD-10: Q14.1, Q13.1
Clinical summary
This genetic test identifies mutations within the PAX6 gene associated with congenital foveal hypoplasia and aniridia.
TEST-6150
PCBD1 Gene Hyperphenylalaninemia, BH4-Deficient, Type D Genetic Test

This test analyzes the PCBD1 gene for pathogenic variants causing BH4-deficient hyperphenylalaninemia type D.

Whole blood, extracted DNA, or dried blood spot (FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PCBD1 gene pathogenic variants", "Tetrahydrobiopterin synthesis disruption"]
Parameters
[]
Preparation
["No fasting necessary"]
Indications
["Diagnosis of BH4-deficient hyperphenylalaninemia type D", "Individuals with elevated phenylalanine levels", "Family history of biopterin synthesis disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48018-6 ICD-10: E70.1
Clinical summary
This test analyzes the PCBD1 gene for pathogenic variants causing BH4-deficient hyperphenylalaninemia type D.
TEST-4294
PCDH19 Gene Early Infantile Epileptic Encephalopathy Type 9 Genetic Test

This genetic test evaluates the PCDH19 gene for mutations associated with Early Infantile Epileptic Encephalopathy Type 9 (EIEE9).

Peripheral Blood (Whole Blood) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PCDH19 gene mutations", "Point mutations", "Small insertions", "Small deletions"]
Parameters
[]
Preparation
[]
Indications
["Suspected Early Infantile Epileptic Encephalopathy Type 9 (EIEE9)", "Diagnosis of severe neurodevelopmental disorder with seizures"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81307-0 ICD-10: G40.89
Clinical summary
This genetic test evaluates the PCDH19 gene for mutations associated with Early Infantile Epileptic Encephalopathy Type 9 (EIEE9).
TEST-5884
PCK1 Gene Phosphoenolpyruvate Carboxykinase Deficiency, Cytosolic Genetic Test

This genetic test identifies pathogenic variants in the PCK1 gene, confirming a diagnosis of cytosolic phosphoenolpyruvate carboxykinase deficiency.

Whole Blood (EDTA), Extracted DNA, Dried Blood Spot (FTA Card) 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PCK1 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "No medication adjustments needed before testing"]
Indications
["Suspected cytosolic phosphoenolpyruvate carboxykinase deficiency", "Family history of the disorder", "Metabolic acidosis-prone patients"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: E74.89
Clinical summary
This genetic test identifies pathogenic variants in the PCK1 gene, confirming a diagnosis of cytosolic phosphoenolpyruvate carboxykinase deficiency.
TEST-6262
PCSK9 Gene Hypercholesterolemia Autosomal Dominant Type 3 Genetic Test

This genetic test identifies pathogenic variants in the PCSK9 gene associated with autosomal dominant hypercholesterolemia type 3.

Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic and likely pathogenic variants in the PCSK9 gene", "Copy Number Variations (CNVs) within the PCSK9 gene"]
Parameters
[]
Preparation
["A detailed clinical history is required.", "A genetic counselling session to draw a pedigree chart is mandatory before sample collection."]
Indications
["Individuals with LDL-C >190 mg/dL", "Family history of early heart disease", "Suspected familial hypercholesterolemia", "Risk stratification for cardiovascular disease", "Guidance for personalized lipid-lowering therapy", "Family cascade screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: E78.01
Clinical summary
This genetic test identifies pathogenic variants in the PCSK9 gene associated with autosomal dominant hypercholesterolemia type 3.
TEST-5819
PDE8B Gene Striatal Degeneration Genetic Test

This genetic test identifies pathogenic variants in the PDE8B gene associated with autosomal recessive striatal degeneration.

Whole blood (EDTA), extracted DNA, or FTA card spot 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the PDE8B gene", "Full gene coding regions and flanking intronic sequences"]
Parameters
[]
Preparation
["No fasting required", "Maintain hydration"]
Indications
["Suspected autosomal recessive striatal degeneration", "Family history of striatal degeneration", "Differential diagnosis of neurodegenerative disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 58795-0 ICD-10: G23.8, G31.89
Clinical summary
This genetic test identifies pathogenic variants in the PDE8B gene associated with autosomal recessive striatal degeneration.
TEST-3067
PDGFB Gene Sequencing Test

This test identifies pathogenic variants in the PDGFB gene associated with Idiopathic Basal Ganglia Calcification Type 5 (IBGC5).

Peripheral Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PDGFB gene sequence", "Pathogenic variants (SNVs, indels, splice-site mutations)", "Coverage of coding exons, splice junctions, and regulatory regions"]
Parameters
[]
Preparation
["Pre-test genetic counselling session required", "Detailed three-generation pedigree chart construction", "No fasting required unless combined with other metabolic tests"]
Indications
["Individuals with bilateral basal ganglia calcification of unknown cause", "Positive family history suggestive of autosomal dominant inheritance", "Paediatric patients with unexplained developmental regression and cerebral calcifications", "Asymptomatic first-degree relatives of a confirmed IBGC5 proband seeking cascade screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21665-7 ICD-10: G23.8
Clinical summary
This test identifies pathogenic variants in the PDGFB gene associated with Idiopathic Basal Ganglia Calcification Type 5 (IBGC5).
TEST-6134
PDHA1 (PDX1) and PDHX Gene Lacticacidemia Genetic Test

This test evaluates the PDHA1 (PDX1) and PDHX genes for pathogenic variants associated with pyruvate dehydrogenase complex deficiency, a cause of primary lactic acidosis.

Peripheral EDTA whole blood (3–5 mL) or extracted genomic DNA (β‰₯1 Β΅g) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in PDHA1 (PDX1) gene", "Pathogenic variants in PDHX gene", "Single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy-number changes (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required for blood sample", "Inform lab of any current medications or dietary regimens"]
Indications
["Individuals with unexplained chronic lactic acidosis", "Neonatal metabolic crises", "Family history of pyruvate dehydrogenase deficiency", "Carrier testing for at-risk relatives", "Preconception screening for couples with a family history of metabolic disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81344-4 ICD-10: E74.81
Clinical summary
This test evaluates the PDHA1 (PDX1) and PDHX genes for pathogenic variants associated with pyruvate dehydrogenase complex deficiency, a cause of primary lactic acidosis.
TEST-5912
PDHA1 Gene Pyruvate Dehydrogenase E1-Alpha Deficiency Genetic Test

This test identifies pathogenic variants in the PDHA1 gene, confirming a diagnosis of pyruvate dehydrogenase E1-alpha deficiency.

Whole blood, extracted DNA, or FTA card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants (SNVs, indels, CNVs) in the PDHA1 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medications without physician approval"]
Indications
["Clinical suspicion of pyruvate dehydrogenase deficiency", "Family screening for confirmed cases", "Carrier testing for family members"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83107-8 ICD-10: E74.4
Clinical summary
This test identifies pathogenic variants in the PDHA1 gene, confirming a diagnosis of pyruvate dehydrogenase E1-alpha deficiency.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area